Retrospective assessment of medication patterns among candidates evaluated for living kidney donation

Author:

Dickinson Drew T.1ORCID,Nguyen Linh1ORCID,Liu Xinqi1ORCID,Castro Gianna1,Cherry Morgan1,Dadabaev Fadel1,Rodriguez Hercys Sanchez2,Malat Gregory E.13,Forte Abigail13ORCID,Dunn Ty B.23ORCID,Redfield Robert R.23,Leonberg‐Yoo Amanda34ORCID,Trofe‐Clark Jennifer1234ORCID

Affiliation:

1. Department of Pharmacy Services Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

2. Department of Surgery, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

3. Penn Medicine Transplant Institute, Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

4. Division of Renal, Electrolyte and Hypertension, Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Abstract

AbstractIntroductionMedication use in living kidney donor (LKD) candidates may have important implications for evaluation and donation care. We sought to characterize LKD candidate medication use through medication histories conducted at nephrologist evaluation and transplant pharmacist preoperative visits.MethodsThis retrospective single‐center cohort study included adult LKD candidates evaluated for donation between October 1, 2019 and October 1, 2021. Scheduled and as‐needed medications for each candidate were abstracted from pre‐donation medication histories collected at the evaluation visit with the nephrologist and the preoperative visit with the transplant pharmacist, if approved for donation. Medication histories from each visit were compared with each other and evaluated by therapeutic class frequency.ResultsAmong 213 LKD candidates (112 approved for donation and 101 declined for donation), 198 (93.0%) candidates were taking at least one prescription medication, over‐the‐counter agent, or dietary supplement. Antidepressants and antihypertensives were the most common prescription agents used among candidates, with antihypertensives more common among declined donors (20.8% vs. 10.7%, p = 0.042). Nonsteroidal anti‐inflammatory drugs were more commonly identified at the evaluation visit of approved candidates compared to the preoperative visit (29.5% vs. 0.9%, p < 0.001) and dietary supplements were more commonly identified at the preoperative visit compared to the evaluation visit (49.1% vs. 59.8%, p = 0.023).ConclusionsThe frequency of nonsteroidal anti‐inflammatory drugs decreased greatly between the evaluation and preoperative visit, likely reflective of discontinuation pre‐donation. Characterizing medication use among candidates evaluated for LKD donation may assist donor programs with developing more targeted patient medication education. Nearly all LKD candidates were taking a medication or dietary supplement pre‐donation. Transplant pharmacists are uniquely positioned to perform medication reconciliations and can also offer guidance to other team providers on best practices for this process. A better understanding of medication patterns in this population may also aid with further developing care guidelines for LKD evaluation and pre‐/postoperative LKD care.

Publisher

Wiley

Reference26 articles.

1. Organ Procurement and Transplant Network.Donors recovered in the U.S. by Donor Type. Available from:https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/. Accessed 12 Aug 2022.

2. Living-donor kidney transplantation: risks of the donor ? benefits of the recipient

3. Evaluation of Kidney Donors: Core Curriculum 2018

4. KDIGO clinical practice guideline on the evaluation and care of living kidney donors;Lentine KL;Transplantation,2017

5. The relationship between marijuana use and psychosocial variables in living kidney donor candidates

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3